128 related articles for article (PubMed ID: 32697854)
1. Interferon: The invisible link in the physiopathology of COVID-19 and BCGitis?
Di Bella S; Cabas P; Antonello RM; Rizzo M
Scand J Immunol; 2020 Dec; 92(6):e12939. PubMed ID: 32697854
[No Abstract] [Full Text] [Related]
2. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
[TBL] [Abstract][Full Text] [Related]
3. Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
Inoue K; Kashima S
PLoS One; 2021; 16(6):e0253169. PubMed ID: 34143810
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
5. Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.
Burl S; Adetifa UJ; Cox M; Touray E; Ota MO; Marchant A; Whittle H; McShane H; Rowland-Jones SL; Flanagan KL
J Immunol; 2010 Aug; 185(4):2620-8. PubMed ID: 20644160
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
7. Variability between countries in cytokine responses to BCG vaccination: what impact might this have on protection?
Dockrell HM; Smith SG; Lalor MK
Expert Rev Vaccines; 2012 Feb; 11(2):121-4. PubMed ID: 22309659
[No Abstract] [Full Text] [Related]
8. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
Front Immunol; 2021; 12():801799. PubMed ID: 35222355
[TBL] [Abstract][Full Text] [Related]
9. M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse model.
Hedhli D; Denis O; Barkan D; Daffé M; Glickman MS; Huygen K
PLoS One; 2013; 8(10):e76442. PubMed ID: 24146869
[TBL] [Abstract][Full Text] [Related]
10. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR
Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400
[TBL] [Abstract][Full Text] [Related]
11. Immunization of newborn and adult mice with low numbers of BCG leads to Th1 responses, Th1 imprints and enhanced protection upon BCG challenge.
Kiros TG; Power CA; Wei G; Bretscher PA
Immunotherapy; 2010 Jan; 2(1):25-35. PubMed ID: 20635889
[TBL] [Abstract][Full Text] [Related]
12. Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.
Nandakumar S; Kannanganat S; Posey JE; Amara RR; Sable SB
PLoS One; 2014; 9(11):e113951. PubMed ID: 25419982
[TBL] [Abstract][Full Text] [Related]
13. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.
Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X
Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity.
Kleinnijenhuis J; Quintin J; Preijers F; Benn CS; Joosten LA; Jacobs C; van Loenhout J; Xavier RJ; Aaby P; van der Meer JW; van Crevel R; Netea MG
J Innate Immun; 2014; 6(2):152-8. PubMed ID: 24192057
[TBL] [Abstract][Full Text] [Related]
15. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
[TBL] [Abstract][Full Text] [Related]
16. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
Abebe F
Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
[TBL] [Abstract][Full Text] [Related]
17. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
[TBL] [Abstract][Full Text] [Related]
18. Parallels in the pathogenesis of SARS-CoV-2 and
Tapela K; Ochieng' Olwal C; Quaye O
Future Microbiol; 2020 Dec; 15():1691-1695. PubMed ID: 33404259
[No Abstract] [Full Text] [Related]
19. Comparative evaluation of MPT83 (Rv2873) for T helper-1 cell reactivity and identification of HLA-promiscuous peptides in Mycobacterium bovis BCG-vaccinated healthy subjects.
Mustafa AS
Clin Vaccine Immunol; 2011 Oct; 18(10):1752-9. PubMed ID: 21852544
[TBL] [Abstract][Full Text] [Related]
20. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
Behr MA; Divangahi M; Schurr E
J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
